News

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...
Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and ...
Accordingly, TB is the top cause of HIV-related deaths in South Africa. Recovering life expectancy Just what a big deal HIV has been in South Africa is clear from estimates of life expectancy in the ...
The first cases of HIV in the U.S. were reported on June 5, 1981. HIV is a virus that attacks a person's immune system, making them vulnerable to disease.
In a video message posted on Facebook, Health Secretary Teodoro Herbosa said the bigger health problem in the Philippines now is not Mpox but HIV. "Five hundred percent increase po tayo ng HIV cases ...
HIV’s Most Promising Breakthrough Has Taken a Hit Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more research.